Effect of Allopurinol in lowering blood pressure in hemodialysis patients

Not Applicable

• Conditions: Condition 1: Hypertension. Condition 2: Hyperuricemia.; Hypertensive renal disease, Hypertensive heart and renal disease , Secondary hypertension; Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease Asymptomatic hyperuricaemia; I12, I13,

• Registration Number: IRCT138902043325N2
• Lead Sponsor: Zanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

having high level of serum uric acid (serum uric acid level greater than 6.5 mg/dl (men) or greater than 5.5 mg/dl (women). This definition was based on analyses from the Atherosclerosis Risk in Communities (ARIC) Study;
Exclusion criteria: uric acid level of serum less than 6.5 for men and less than 5.5 for women, known history of allopurinol hypersensitivity or those who already were on allopurinol

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: Baseline, at the beginning of each phase, each week for 3 month during each phase. Method of measurement: sphygmomanometer.

Secondary Outcome Measures

Name	Time	Method
Blood level of uric acid. Timepoint: at the begining of study and after 3 months. Method of measurement: laboratory techniques.